Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Histopathology

Retrieve available abstracts of 40 articles:
HTML format

Single Articles

    December 2022
  1. NUTI S, Zhang Y, Zerrouki N, Roach C, et al
    High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.
    Histopathology. 2022;81:732-741.
    PubMed     Abstract available

  2. GAO HW, Sun PL
    Pulmonary sialadenoma papilliferum and its mimics: what you need to know.
    Histopathology. 2022;81:715-723.
    PubMed     Abstract available

    November 2022
  3. XU B, Viswanathan K, Umrau K, Al-Ameri TAD, et al
    Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.
    Histopathology. 2022;81:670-679.
    PubMed     Abstract available

    August 2022
    The metamorphosis of papillary thyroid carcinoma.
    Histopathology. 2022;81:168-170.

    June 2022
  5. KOUZU K, Nearchou IP, Kajiwara Y, Tsujimoto H, et al
    Deep learning-based classification of desmoplastic reaction on H&E predicts poor prognosis in esophageal squamous cell carcinoma.
    Histopathology. 2022 Jun 27. doi: 10.1111/his.14708.
    PubMed     Abstract available

  6. ANGERILLI V, Lonardi S, Farinati F, Savarino E, et al
    Mismatch repair status and gastro-oesophageal dysplasia: need for a dedicated gastrointestinal pathologist?
    Histopathology. 2022;80:1138-1140.

  7. JANUSZEWICZ W, Pilonis ND, Sawas T, Phillips R, et al
    The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.
    Histopathology. 2022;80:1081-1090.
    PubMed     Abstract available

    May 2022
  8. GRAHAM MARTINEZ C, Kus Ozturk S, Al-Kaabi A, Valkema MJ, et al
    Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance.
    Histopathology. 2022;80:982-994.
    PubMed     Abstract available

  9. TAKEMURA C, Kashima J, Hashimoto T, Ichikawa H, et al
    A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma.
    Histopathology. 2022;80:1004-1007.

    April 2022
  10. XU B, Viswanathan K, Zhang L, Edmund LN, et al
    Redefining the Solid Variant of Papillary Thyroid Carcinoma: A Multi-institutional Retrospective Study.
    Histopathology. 2022 Apr 26. doi: 10.1111/his.14668.
    PubMed     Abstract available

    March 2022
  11. LI ZW, He L, Zheng Z, Zhang Q, et al
    Combined assessment of tumor cell nest size and desmoplastic reaction as an excellent prognostic predictor in esophageal squamous cell carcinoma.
    Histopathology. 2022 Mar 30. doi: 10.1111/his.14657.
    PubMed     Abstract available

  12. NAKANO S, Okumura Y, Murase T, Nagao T, et al
    Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
    Histopathology. 2022;80:729-735.
    PubMed     Abstract available

    February 2022
  13. KARAMCHANDANI DM, Go P, Bayerl M, Karamchandani K, et al
    Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall.
    Histopathology. 2022;80:604-606.

    January 2022
  14. KARAMCHANDANI DM, Gonzalez RS, Westerhoff M, Westbrook LM, et al
    Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?
    Histopathology. 2022;80:420-429.
    PubMed     Abstract available

  15. CERBELLI B, Girolami I, Eccher A, Costarelli L, et al
    Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study.
    Histopathology. 2022;80:397-406.
    PubMed     Abstract available

    December 2021
  16. MA S, Zhao D, Liu Y, Rohr J, et al
    Some pleomorphic adenomas of the breast share PLAG1 rearrangements with the analogous tumour of the salivary glands.
    Histopathology. 2021;79:1030-1039.
    PubMed     Abstract available

  17. GOTO K, Kukita Y, Honma K, Ogawa K, et al
    Signet-ring cell/histiocytoid carcinoma of the axilla: a clinicopathological and genetic analysis of 11 cases, review of the literature, and comparison with potentially related tumours.
    Histopathology. 2021;79:926-939.
    PubMed     Abstract available

    November 2021
  18. IHRLER S, Agaimy A, Guntinas-Lichius O, Haas CJ, et al
    Why is the histomorphological diagnosis of tumours of minor salivary glands much more difficult?
    Histopathology. 2021;79:779-790.
    PubMed     Abstract available

    October 2021
  19. JUHLIN CC, Stenman A, Zedenius J
    Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.
    Histopathology. 2021;79:661-666.
    PubMed     Abstract available

  20. SALIBA M, Katabi N, Dogan S, Xu B, et al
    NRAS Q61R immunohistochemical staining in thyroid pathology: sensitivity, specificity and utility.
    Histopathology. 2021;79:650-660.
    PubMed     Abstract available

  21. HAMAMOTO Y, Kukita Y, Kitamura M, Kurashige M, et al
    Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Histopathology. 2021;79:521-532.
    PubMed     Abstract available

    September 2021
  22. BENZERDJEB N, Tantot J, Blanchet C, Philouze P, et al
    Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
    Histopathology. 2021;79:381-390.
    PubMed     Abstract available

  23. ZHAI C, Wang H, Li S, Wang D, et al
    Clinicopathological analysis of low-grade papillary Schneiderian carcinoma: report of five new cases and review of the literature.
    Histopathology. 2021;79:370-380.
    PubMed     Abstract available

  24. JIROMARU R, Yamamoto H, Yasumatsu R, Hongo T, et al
    p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma.
    Histopathology. 2021;79:358-369.
    PubMed     Abstract available

  25. XU B, Suurmeijer AJH, Agaram NP, Zhang L, et al
    Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
    Histopathology. 2021;79:347-357.
    PubMed     Abstract available

  26. HERNANDEZ-PRERA JC, Skalova A, Franchi A, Rinaldo A, et al
    Pleomorphic adenoma: the great mimicker of malignancy.
    Histopathology. 2021;79:279-290.
    PubMed     Abstract available

  27. BISHOP JA, Nakaguro M, Whaley RD, Ogura K, et al
    Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
    Histopathology. 2021;79:338-346.
    PubMed     Abstract available

  28. SALAMA AM, Valero C, Katabi N, Khimraj A, et al
    Depth of invasion versus tumour thickness in early oral tongue squamous cell carcinoma: which measurement is the most practical and predictive of outcome?
    Histopathology. 2021;79:325-337.
    PubMed     Abstract available

  29. TAVERNA C, Pollastri F, Pecci R, Giannoni B, et al
    Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours.
    Histopathology. 2021;79:306-314.
    PubMed     Abstract available

  30. TAVERNA C, Baneckova M, Lorenzon M, Palomba A, et al
    MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
    Histopathology. 2021;79:315-324.
    PubMed     Abstract available

    August 2021
  31. XU B, David J, Dogan S, Landa I, et al
    Primary High Grade Non-Anaplastic Thyroid Carcinoma: A Retrospective Study of 364 Cases.
    Histopathology. 2021 Aug 27. doi: 10.1111/his.14550.
    PubMed     Abstract available

  32. KOEMANS WJ, van Dieren JM, van den Berg JG, Meijer GA, et al
    High CD8(+) tumour-infiltrating lymphocyte density associates with unfavourable prognosis in oesophageal adenocarcinoma following poor response to neoadjuvant chemoradiotherapy.
    Histopathology. 2021;79:238-251.
    PubMed     Abstract available

  33. SAKAI A, Nakashima Y, Miyashita Y, Ao T, et al
    Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma.
    Histopathology. 2021;79:219-226.
    PubMed     Abstract available

    May 2021
  34. ISIDRO RA, Dong F, Hornick JL, Wee JO, et al
    Verrucous Carcinoma of the Esophagus Is A Genetically Distinct Subtype of Esophageal Squamous Cell Carcinoma.
    Histopathology. 2021 May 7. doi: 10.1111/his.14395.
    PubMed     Abstract available

  35. FORGO E, Hornick JL, Charville GW
    MUC4 is expressed in alveolar rhabdomyosarcoma.
    Histopathology. 2021;78:905-908.
    PubMed     Abstract available

    March 2021
  36. GHOSSEIN CA, Khimraj A, Dogan S, Xu B, et al
    Metastasis to the thyroid gland: a single-institution 16-year experience.
    Histopathology. 2021;78:508-519.
    PubMed     Abstract available

    January 2021
  37. TSUYAMA S, Kohsaka S, Hayashi T, Suehara Y, et al
    Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus.
    Histopathology. 2021;78:240-251.
    PubMed     Abstract available

  38. ROSENBAUM MW, Gonzalez RS
    Targeted therapy for upper gastrointestinal tract cancer: current and future prospects.
    Histopathology. 2021;78:148-161.
    PubMed     Abstract available

  39. PAPKE DJ JR, Hornick JL
    Recent developments in gastroesophageal mesenchymal tumours.
    Histopathology. 2021;78:171-186.
    PubMed     Abstract available

  40. KUMARASINGHE MP, Armstrong M, Foo J, Raftopoulos SC, et al
    The modern management of Barrett's oesophagus and related neoplasia: role of pathology.
    Histopathology. 2021;78:18-38.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.